Inpart

About Inpart

Inpart, formed from the merger of Inova and IN-PART, is a leading digital platform specializing in scientific partnering and research commercialization. Headquartered in Lyon, France, Inpart combines Inova's expertise in biopharma partnership management with IN-PART's online matchmaking technology to create a centralized solution for connecting academia, biotech, startups, and industry partners.

The platform enables users to source leads, triage opportunities, execute deals, and manage alliances-all within a unified environment. This integration streamlines the entire lifecycle of research partnership management, from initial discovery to commercialization, removing much of the manual work associated with traditional systems. Inpart’s tools facilitate showcasing innovations, identifying untapped science, accelerating deal-making, and optimizing collaboration tracking for R&D teams, tech transfer offices, and venture capital firms.

Inpart’s system is designed to aggregate third-party data sources, providing intelligent research commercialization insights. The platform supports both directions of collaboration: universities and research institutes can present their technologies to industry, while companies can search for specific innovations or post technology needs, receiving tailored matches and notifications. This dynamic approach enhances the visibility of research outputs and increases the chances of successful partnerships.

With a strong focus on development-80% of its R&D efforts are dedicated to platform advancement-Inpart aims to further grow its technical team and expand its capabilities. The company’s mission is to accelerate the journey of scientific discoveries from the laboratory to practical applications, whether in healthcare, agriculture, or environmental technology.